Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Atlanta, Georgia 30328


Prospective, randomized, single site study to determine the safety and effectiveness of performing corneal collagen cross-linking (CCCL)using riboflavin and UVA light in eyes with corneal ectasia or progressive keratoconus.

Study summary:

Subjects are randomized to a control group or a treatment group, with the control group crossed over to the treatment group at the 3 month visit. Corneal collagen cross-linking is performed as a single treatment. Subjects are followed for at least 12 months to evaluate the long term effects of corneal collagen cross-linking. Subjects may be referred from other physicians but must return to Emory Vision for completion of all study visits.


Inclusion Criteria: - Diagnosis of keratoconus with documented progression over the previous 12 months. - Diagnosis of corneal ectasia - Must be able to complete all study visits Exclusion Criteria: - Prior corneal surgery in the keratoconus group - Corneal scarring



Primary Contact:

Principal Investigator
R. Doyle Stulting, MD, PhD
Emory Vision; Emory University

Backup Contact:


Location Contact:

Atlanta, Georgia 30328
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.